Sexually Transmitted Disease (STD) Self-Testing Market Forecast 2026–2035: Data Trends and Industry Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the sexually transmitted disease (std) self-testing market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Sexually Transmitted Disease (STD) Self-Testing Market’s size between 2026 and 2030?
The sexually transmitted disease (std) self-testing market size has experienced substantial expansion in recent years. This market is forecasted to expand from $1.52 billion in 2025 to $1.67 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. The growth observed in prior periods can be attributed to factors such as limited public awareness about std testing, the social stigma connected with clinic visits, a dependence on hospital-based testing facilities, the absence of accessible testing options, and an increasing occurrence of sexually transmitted diseases.
The market for sexually transmitted disease (STD) self-testing is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. Key factors contributing to this projected growth include the widespread adoption of digital health platforms, the incorporation of multi-sample at-home testing kits, increased government initiatives for awareness, a rise in telehealth consultations, and advances in rapid and precise diagnostic technologies. Noteworthy trends expected during this period encompass a growing demand for at-home STD testing kits, enhanced public understanding of sexual health and the importance of early diagnosis, the expansion of telehealth and remote consultation services, broader availability through online and retail pharmacy distribution, and the incorporation of multi-sample testing options (such as blood, urine, and oral samples).
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
Which Drivers Are Shaping Strategic Decisions In The Sexually Transmitted Disease (STD) Self-Testing Market?
An increasing occurrence of syphilis is projected to drive expansion within the sexually transmitted disease (STD) self-testing market in the future. Syphilis, an STI, manifests as bodily sores and can result in severe health complications if left untreated. The rise in syphilis cases is attributed to a reduction in regular condom usage, especially within groups participating in risky sexual activities. At-home STD self-testing offers a discreet and accessible way to screen for syphilis, thus encouraging prompt diagnosis. Such timely detection facilitates immediate treatment, thereby reducing complications and hindering its continued transmission. As an illustration, in September 2025, the Centers for Disease Control and Prevention, a US government agency, reported approximately 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases recorded in 2022. Consequently, the growing frequency of syphilis cases is fueling the expansion of the sexually transmitted disease (STD) self-testing market.
What Segment Categories Are Covered In The Sexually Transmitted Disease (STD) Self-Testing Market?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
What Trends Are Expected To Impact The Competitive Landscape Of The Sexually Transmitted Disease (STD) Self-Testing Market?
Major companies operating in the STD self-testing market are prioritizing the development of advanced products, including over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic tools that enable individuals to collect samples, such as urine or swabs, without needing a prescription. These kits offer a convenient and confidential approach to identify infections early, facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, launched the CheckMeSafe home collection kit designed for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their residence. Users can mail their samples to the laboratory using a prepaid overnight label and expect confidential, reliable results in as little as two days. The kit delivers highly accurate results, boasting sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are processed in a CLIA-certified and CAP-accredited laboratory, ensuring adherence to strict federal and state quality standards through routine inspections.
Which Leading Companies Dominate The Sexually Transmitted Disease (STD) Self-Testing Market Share?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Access The Complete Report For Deeper Market Insights:
How Does The Sexually Transmitted Disease (STD) Self-Testing Market Perform Across Major Global Regions?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Sexually Transmitted Disease (STD) Self-Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company
Std Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Sexually Transmitted Infections Stis Market Report 2026
Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
